Significant cost advantage in industrialized production of retroviral vectors
On June 27-28, 2022, the fourth Biouture 2022 Biomedicine Future Leaders Summit was held in Shenzhen, Guangdong as scheduled. Professor Shi Yuanyuan, founder of Shenzhen Cell Valley, was invited to attend the meeting and delivered a wonderful keynote speech entitled Retrovirus or Lentivirus? That is the question.
